Skip to content
The Nexus
DossierENTITY

patent wars

Coverage of patent wars in the Nexus archive.

Earliest in view: Jul 28 · 08:30 UTCMost recent: Jul 28 · 08:30 UTC
Co-mentioned in this coverage
alpha-1 antitrypsin deficiency (AATD)topic1biotechsorganization1U.S. drug industryorganization1Chinese drug industryorganization1alpha-1 antitrypsintopic1
Recent coverage
  • HEALTHJul 28 · 08:30 UTCSTAT NEWS
    From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD

    Biotechs are investing billions to develop a cure for alpha-1 antitrypsin deficiency (AATD), a rare liver disorder caused by a DNA mutation. The race involves U.S. and Chinese drug industries competing with dueling technologies, patent disputes, and a fractured alliance, highlighting intense global competition.

patent wars · Dossier · The Nexus